Enzo Biochem, Inc. (NYSE:ENZ)

CAPS Rating: 1 out of 5

The Company is a life sciences and biotechnology company focused on harnessing genetic processes to develop research tools, diagnostics and therapeutics and a provider of diagnostic services to the medical community.

Recs

5
Player Avatar zzlangerhans (99.77) Submitted: 5/25/2010 4:10:08 PM : Outperform Start Price: $4.94 ENZ Score: -73.03

I was just scavenging around for some green thumbs to take advantage of a market rebound and I found my old friend Enzo, who has recently returned to my fold of score leaders. Enzo is a cyclical, catalyst-deprived biotech currently trading towards the low end of yearly range. Revenues have been essentially static and the pipeline has been quiescent. There's nothing remotely inspiring about Enzo these days except for the low price.

Featured Broker Partners


Advertisement